4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001641172-25-005606
CEO and CFO bought 5,400 shares at $8.98 ($48,492)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-04-17 | Purchase | +5,400 | $8.98 | $48,492 | 5,567,002 | D |
| Open-market purchases · 5,400 sh · avg $8.98 · $48,492 | |||||||
Loading xslF345X05/ownership.xml…